FDAnews Drug Daily Bulletin

ADIPOGENIX AND UNIGEN ENTER JOINT AGREEMENT TO DISCOVER AND DEVELOP PLANT-BASED THERAPEUTICS THAT TARGET FAT

April 7, 2006
A A

AdipoGenix Inc. and Unigen Pharmaceuticals, Inc. today announced that they have entered into an agreement for the joint discovery and development of natural products that target human fat. AdipoGenix is a biopharmaceutical company developing small molecule therapies for obesity, type 2 diabetes and associated morbidities, and Unigen is a leading natural products research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-06-2006/0004335399&EDATE=)